RK-33 - DDX3 inhibitor. CAS# 1070773-09-9 Catalog No.:M6511-2 Fragment-based Discovery of a Small-Molecule

Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues

Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics

Reproduction

1'-biphenyl]-2-yl)methoxy)phenyl)propanoic acid

Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes

RK-33 - DDX3 inhibitor. CAS# 1070773-09-9 Catalog No.:M6511-2 Fragment-based Discovery of a Small-MoleculeDDX3 inhibitor, CAS No. 1070773 09 9, RK 33 binds to DDX3 and abrogates its activity. Inhibition of DDX3 by RK 33 caused G1 cell cycle arrest, induced apoptosis, and promoted radiation sensitization in DDX3 overexpressing cells. Overall, inhibition of DDX3 by RK 33 promotes tumor regression, thus providing a compelling argument to develop DDX3 inhibitors for lung cancer therapy. RK 33 radiosensitizes prostate cancer cells by blocking the RNA helicase